WebVibegron is used to treat overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination) in adults. Vibegron is in a class of medications called beta-3 adrenergic agonists. It works by relaxing the bladder muscles to increase bladder ... WebFeb 1, 2024 · Gemtesa; Descriptions. Vibegron is used to treat symptoms of an overactive bladder. It helps control urinary incontinence (a strong need to urinate with leaking or wetting accidents), urgency or the need to urinate right away, and the need to urinate often. Vibegron relaxes the muscles of the bladder to prevent them from causing incontinence.
Gemtesa (vibegron): Basics, Side Effects & Reviews
WebYou may pay as little as$95 for each 30-day supply if*: You have commercial insurance (government plans like Medicare or Medicaid are not eligible) GEMTESA is not covered by your plan. ESTIMATE COST. For questions about this program, please call 1-833-UROVANT (876 -8268). * Restrictions and maximum saving limits apply. WebApr 26, 2024 · How to Take and Store. Store at room temperature (between 68 and 77 F) Keep in a safe place and out of the reach of children. Dispose of any unused pills safely by … bat if exists ワイルドカード
Gemtesa: Uses, Dosage, Side Effects, Warnings - Drugs.com
WebJan 11, 2024 · The FDA approved GEMTESA based on evidence from one clinical trial (Trial 1/ NCT03492281) of 1085 adult patients 18 to 93 years old with OAB. The trial was … WebDec 3, 2024 · However, while side effects of Gemtesa are uncommon, they do occur. In Gemtesa’s clinical studies, these were some of the side effects that occurred more often: headache. runny or stuffy nose. nausea. upper respiratory tract infection, such as the common cold. urinary tract infection (UTI) *. diarrhea *. WebIn a 12-week clinical study: People taking GEMTESA had 2 fewer daily leakage episodes compared with about 1 (-1.4) fewer episode for those taking placebo.*. People taking GEMTESA had nearly 2 (-1.8) fewer bathroom visits per day compared with about 1 (-1.3) fewer visit per day for those taking placebo. †. 卒業 斉藤由貴 カバー